[EN] DIHYDROPYRIMIDOPYRIMIDINE DERIVATIVE<br/>[FR] DÉRIVÉ DE DIHYDROPYRIMIDOPYRIMIDINE
申请人:BANYU PHARMA CO LTD
公开号:WO2010067886A1
公开(公告)日:2010-06-17
The present invention relates to a compound of General Formula (I) below, among others. In the Formula, Ar1 is an optionally substituted aryl or heteroaryl group; R1 is a hydrogen atom, an optionally substituted C1-C6 alkyl group, or an optionally substituted aryl, aralkyl, or heteroaryl group; R2 is an optionally substituted aryl, aralkyl, or heteroaryl group; and R3 is a hydrogen atom or a C1-C6 alkyl group. A compound of the present invention has an excellent Wee1 kinase inhibiting effect, and is therefore useful in the filed of medicine, particularly in various types of cancer therapy.
本发明涉及一种通式(I)的化合物,其中Ar1是一个可选取代的芳基或杂环芳基基团;R1是氢原子,可选取代的C1-C6烷基基团,或可选取代的芳基、芳基烷基或杂环芳基基团;R2是可选取代的芳基、芳基烷基或杂环芳基基团;R3是氢原子或C1-C6烷基基团。本发明的化合物具有出色的Wee1激酶抑制作用,因此在医学领域特别是各种癌症治疗方面非常有用。